In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...

Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated ...

La compañía farmacéutica Pfizer ha estado involucrada en litigios relacionados con el medicamento Zantac desde febrero de 2020, según se revela en sus presentaciones ante la Comisión de Bolsa y ...

Pharmaceutical giant Pfizer has settled over 10,000 lawsuits accusing the company of concealing cancer risks associated with its antacid medication, Zantac. The lawsuits, filed in courts across the ...

La compañía farmacéutica Pfizer pagará hasta 250 millones de dólares (229 millones de euros) para resolver más de 10.000 demandas en Estados Unidos sobre riesgos de cáncer asociados con su medicamento ...

Pfizer has reached a major settlement in a legal battle concerning its recalled heartburn medication, Zantac. According to a Bloomberg report, Pfizer has agreed to settle over 10,000 lawsuits that ...

Moderna (MRNA) y Pfizer (NYSE:PFE) mantienen actualmente conversaciones con el Gobierno de Estados Unidos sobre el desarrollo de vacunas contra la cepa H5N1 de la gripe aviar,... Mostrar más ...

Estimación del precio real de una acción basada en modelos de valoración como el flujo de caja descontado, los múltiplos de valoración por pares y los modelos de descuento de dividendos.